Can Finerenone Alter Glomerular Disease Trajectory? - Top_Thought_Leaders - MDSpire

Can Finerenone Alter Glomerular Disease Trajectory?

A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.

  • By

  • Kathryn Wighton

  • June 5, 2026

  • 4 min

Share

Top Thought Leaders in General Medicine

Brief introduction explaining scope and methodology.

Original Source(s)

Can Finerenone Alter Glomerular Disease Trajectory?

  • by Kathryn Wighton

  • June 5, 2026

Related Content

Congo Ebola Outbreak Strains Care Delivery

“We live with fear in our stomachs"

Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure

Latent transition analysis of home-based fluid management during the vulnerable phase in patients with chronic heart failure: impact on symptom burden